- Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
More ▼
Key statistics
As of last trade, Enanta Pharmaceuticals Inc (ENTA:NSQ) traded at 13.65, 68.94% above the 52 week low of 8.08 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.87 |
---|---|
High | 13.94 |
Low | 13.31 |
Bid | 13.65 |
Offer | 13.67 |
Previous close | 14.00 |
Average volume | 180.53k |
---|---|
Shares outstanding | 21.16m |
Free float | 19.87m |
P/E (TTM) | -- |
Market cap | 296.18m USD |
EPS (TTM) | -6.56 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 18:13 BST.
More ▼